Anti-SIGIR/ SIGIRR/ IL-1R8 monoclonal antibody

Anti-SIGIR/ SIGIRR/ IL-1R8 antibody for FACS & in-vivo assay

Target products collectionGo to SIGIRR/SIGIRR products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1516-Ab-1/ GM-Tg-hg-MP1516-Ab-2Anti-Human SIGIRR monoclonal antibodyHuman
GM-Tg-rg-MP1516-Ab-1/ GM-Tg-rg-MP1516-Ab-2Anti-Rat SIGIRR monoclonal antibodyRat
GM-Tg-mg-MP1516-Ab-1/ GM-Tg-mg-MP1516-Ab-2Anti-Mouse SIGIRR monoclonal antibodyMouse
GM-Tg-cynog-MP1516-Ab-1/ GM-Tg-cynog-MP1516-Ab-2Anti-Cynomolgus/ Rhesus macaque SIGIRR monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1516-Ab-1/ GM-Tg-felg-MP1516-Ab-2Anti-Feline SIGIRR monoclonal antibodyFeline
GM-Tg-cang-MP1516-Ab-1/ GM-Tg-cang-MP1516-Ab-2Anti-Canine SIGIRR monoclonal antibodyCanine
GM-Tg-bovg-MP1516-Ab-1/ GM-Tg-bovg-MP1516-Ab-2Anti-Bovine SIGIRR monoclonal antibodyBovine
GM-Tg-equg-MP1516-Ab-1/ GM-Tg-equg-MP1516-Ab-2Anti-Equine SIGIRR monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1516-Ab-1/ GM-Tg-hg-MP1516-Ab-2; GM-Tg-rg-MP1516-Ab-1/ GM-Tg-rg-MP1516-Ab-2;
GM-Tg-mg-MP1516-Ab-1/ GM-Tg-mg-MP1516-Ab-2; GM-Tg-cynog-MP1516-Ab-1/ GM-Tg-cynog-MP1516-Ab-2;
GM-Tg-felg-MP1516-Ab-1/ GM-Tg-felg-MP1516-Ab-2; GM-Tg-cang-MP1516-Ab-1/ GM-Tg-cang-MP1516-Ab-2;
GM-Tg-bovg-MP1516-Ab-1/ GM-Tg-bovg-MP1516-Ab-2; GM-Tg-equg-MP1516-Ab-1/ GM-Tg-equg-MP1516-Ab-2
Products NameAnti-SIGIRR monoclonal antibody
Formatmab
Target NameSIGIRR
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SIGIRR benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SIGIR/ SIGIRR/ IL-1R8 VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-MP1516-Ag-1single immunoglobulin and toll-interleukin 1 receptor (TIR) domain (SIGIRR) protein
    ORF Viral VectorpGMLV000704human SIGIRR Lentivirus plasmid
    ORF Viral VectorpGMAP000069Human SIGIRR Adenovirus plasmid
    ORF Viral VectorvGMAP000069Human SIGIRR Adenovirus particle
    ORF Viral VectorvGMLV000704human SIGIRR Lentivirus particle
    ORF Viral VectorpGMAD000320mouse Sigirr Adenovirus plasmid
    ORF Viral VectorvGMAD000320mouse Sigirr Adenovirus particle


    Target information

    Target IDGM-MP1516
    Target NameSIGIRR
    Gene ID59307,24058,309106,100686933,101100416,531801,100054544
    Gene Symbol and SynonymsIL-1R8,RGD1306732,SIGIRR,TIR8
    Uniprot AccessionQ6IA17,Q4V892
    Uniprot Entry NameSIGIR_HUMAN,SIGIR_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryCytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000185187
    Target ClassificationN/A

    The target: SIGIRR, gene name: SIGIRR, also named as IL-1R8, TIR8. Predicted to enable NAD+ nucleosidase activity. Involved in negative regulation of DNA-binding transcription factor activity. Located in membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.